Young Adult Cancer Survivors May Face Elevated Social Risks
Social risks include insecure access to living essentials and affordable health care, as well as psychological issues BALTIMORE –...
Search/Filter
Loading...
Obesity-associated Cancers May Be on the Rise in Puerto Rico
BALTIMORE – The incidence of obesity-associated cancers in Puerto Rico rose significantly between 2000 and 2022, according to research...
Self-collection for HPV Testing Can Improve Cervical Cancer Screening Rates Among Asian American Women
An HPV self-sampling option vastly increased engagement in cervical cancer screening among Korean, Vietnamese, and Chinese women in the...
AACR Past President Frank McCormick, PhD, FAACR, to Receive the Inaugural Stephenson Global Prize
The $1 million prize will be presented at the AACR Special Conference on Advances in Pancreatic Cancer Research later...
Cancer-related Fatigue and Depression May Lead to Decrease in Recreational Physical Activities and Quality of Life in Survivors
Female cancer survivors were 69% more likely to experience cancer-related fatigue and 58% more likely to experience depression than...
Patient Outcomes May Improve With Tailored Treatment Guided by Tissue Plus Liquid Biopsies vs. Individually
Treatment guided by both tests led to better outcomes than standard of care CHICAGO – Patients with advanced solid...
Breast Cancer Mortality in Women Ages 20-49 Significantly Dropped Between 2010 and 2020
CHICAGO – From 2010 to 2020, breast cancer deaths among women ages 20-49 declined significantly across all breast cancer...
Single-cell RNA Sequencing Provides Comprehensive Map of Acute Myeloid Leukemia Cell States
Study establishes a reference for normal hematopoietic cell differentiation and identifies novel acute myeloid leukemia cell states with potential...
American Association for Cancer Research Inaugurates New Leadership During AACR Annual Meeting 2025
Lillian L. Siu, MD, FAACR, begins term as AACR President CHICAGO – The members of the American Association for...
Oral HER2-targeted Therapy Zongertinib Demonstrates Clinical Benefit in Advanced HER2-mutated Lung Cancer
CHICAGO – Zongertinib, a human epidermal growth factor receptor 2 (HER2)-targeted tyrosine kinase inhibitor, elicited durable responses in patients...